Oregon's Series 2006A COPs Rated 'A+'; Outlook Stable May 06

  • ID: 1806821
  • May 2006
  • Region: Oregon
  • Standard & Poors
1 of 3


  • Oregon
  • Oregon Dept of Admin Svcs
  • MORE

NEW YORK (Standard & Poor's) May 2, 2006--Standard & Poor's Ratings Services assigned its 'A+' rating to Oregon's $94.83 million certificates of participation (COPs) series 2006A, issued for Oregon Department of Administrative Services. The rating is based on the general creditworthiness of the state, coupled with state loan payments subject to appropriation. The outlook is stable, mirroring the outlook on the state's GO rating. Proceeds of the series 2006A COPs will be used for a number of projects, although mainly for financing a portion of the cost of constructing the 1,240-bed medium-security Madras Prison Facility. The total cost of the facility is estimated at $173 million, with construction completion anticipated in May 2007. The facility, financed in part by a...

Companies mentioned in this report are:
- Oregon Dept of Admin Svcs
- Oregon

Action: New Rating
Action: Outlook: Stable

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Oregon Dept of Admin Svcs
- Oregon

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.